Stay updated on VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial

Sign up to get notified when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The VIP152 trial record for relapsed/refractory chronic lymphocytic leukemia or Richter syndrome is displayed, with details on study design, participant criteria, locations, and measures. The record indicates the study was terminated due to slow enrollment and is no longer recruiting.
    Difference
    47%
    Check dated 2026-11-08T10:39:47.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T12:01:10.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A notice appears above the ClinicalTrials.gov navigation announcing NIH website updates and a terminology transition. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T12:16:09.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:15:11.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1; the study page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T13:50:52.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Access to the study record has been replaced by a 403 Forbidden error page. The error page blocks the display of the trial details and related content.
    Difference
    18%
    Check dated 2026-09-20T19:23:30.000Z thumbnail image

Stay in the know with updates to VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.